Abbas Mirshafiey

12PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Bioinformatic methods developmentCellular immunologyGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 30, 2025
Toll-like Receptor 2 Signaling Abnormalities Are Associated with Clinical Manifestations in Common Variable Immunodeficiency.

Hassan Abolhassani, Nima Rezaei, Reza Yazdani

|Apr 19, 2023
The Open, Randomized, Positive Control Clinical Trial of Guluronic Acid (G2013) on SARS-CoV-2 Patients.

Zahra Aghazadeh, Davod Sanaee Delir, Hamid Reza Gholamrezaie

|Aug 19, 2022
Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study.

Fatemeh Sana Askari, Mohsen Ebrahimi, Jabbar Parhiz

|Mar 19, 2022
Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects.

Farzaneh Tofighi Zavareh, Abbas Mirshafiey, Reza Yazdani

|Oct 26, 2021
Evaluation of G2013 (α-L-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors.

Zahra Bagherian, Abbas Mirshafiey, Monireh Mohsenzadegan

Pageof 2